TELA Bio, Inc. (TELA)

TELA Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 6, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	36	119	162	220	186	217
Market Cap Growth	-65.49%	-26.63%	-26.42%	18.68%	-14.47%	46.96%
Enterprise Value	50	145	146	207	163	166
Last Close Price	0.81	3.02	6.62	11.50	12.80	15.04
PS Ratio	0.46	1.72	2.77	5.32	6.30	11.92
PB Ratio	21.01	4.18	8.59	15.40	9.24	4.43
P/TBV Ratio	350.54	4.45	9.67	18.66	10.43	4.68
EV/Sales Ratio	0.65	2.09	2.49	5.01	5.54	9.13
Debt / Equity Ratio	27.99	1.51	2.27	2.81	1.57	0.63
Asset Turnover	1.35	0.84	0.80	0.64	0.40	0.24
Inventory Turnover	1.98	1.73	1.44	1.40	1.79	1.57
Quick Ratio	2.41	4.02	3.33	3.92	4.56	11.67
Current Ratio	3.30	5.01	4.23	5.04	5.58	12.60
Return on Equity (ROE)	-	-159.87%	-281.23%	-257.51%	-96.28%	-72.00%
Return on Assets (ROA)	-38.68%	-31.66%	-37.76%	-37.39%	-24.71%	-20.46%
Return on Capital Employed (ROCE)	-79.50%	-58.70%	-72.20%	-70.30%	-56.70%	-31.70%
Earnings Yield	-108.01%	-31.81%	-28.78%	-20.10%	-17.92%	-13.26%
FCF Yield	-87.25%	-35.80%	-25.58%	-18.89%	-16.73%	-11.34%
Buyback Yield / Dilution	-78.98%	-24.74%	-40.58%	-12.40%	-11.90%	-632.24%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q